MG
Montreal Gazette
›United Steelworkers women from across Canada and the U.S. attend international union conference in Toronto›Car torched in Rivière-des-Prairies›Cole Caufield lives up to Mr. Saturday Night nickname | HI/O Bonus›Letters: Vanier should apologize and reschedule Holocaust commemoration›About Last Night: Jacob Fowler loses shutout on flukey goal›French far-left politician bound for Montreal says Canada blocked her entry over Gaza views›Hidden Game: Canadiens toy with Predators to win fourth straight to begin crucial road trip›Liveblog replay: Cole Caufield scores 45th, Canadiens beat Predators 4-1›Catherine Dubois scores two goals to lead Victoire over Sirens›André Pratte: Why I’m returning to Quebec politics at a ‘crucial’ time›Drainville questions Fréchette’s ability to govern as last debate gets emotional›Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care›Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity›Stu’s Slapshots: Canadiens silence Jakub Dobes›Mulvihill Enhanced Split Preferred Share ETF Announces Year End Results›Premium Global Income Split Corp. Announces Year End Results›Mulvihill Premium Yield Fund Announces Year End Results›Mulvihill Canadian Bank Enhanced Yield ETF Announces Year End Results›Montreal teen falls through ice into river and vanishes. Here’s what we know so far›AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis
Last updated: May 26, 2026, 4:30 p.m.